Efficacy of daratumumab on multiple myeloma patients with renal insufficiency: a systematic review and meta-analysis
H Jiang, L Li, M Guo, M Li, H Wu, X Chen, M Gao… - …, 2024 - Taylor & Francis
Background Renal insufficiency (RI) is a key factor affecting the prognosis of multiple
myeloma (MM) patients. Because the benefit of daratumumab for treating MM patients with …
myeloma (MM) patients. Because the benefit of daratumumab for treating MM patients with …